FDA Inspection 1016256 — Creative Testing Solutions

Creative Testing Solutions — FEI 1071905

The FDA completed an inspection of Creative Testing Solutions on May 25, 2017 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Memphis, TN (United States)